Epigenetic regulation of EMT: The snail story

Current Pharmaceutical Design

Volumn 20, Issue 11, 2014, Pages 1698-1705

  Lin, Yiwei ^a   Dong, Chenfang ^a   Zhou, Binhua P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

EMT; Epigenetic regulation; Snail

Indexed keywords

HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; CADHERIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; DEACETYLATION; DEMETHYLATION; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HISTONE METHYLATION; HISTONE MODIFICATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; HUMAN; METASTASIS;

ANIMALS; CADHERINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84903747460     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990512     Document Type: Article

References (117)

1. Christofori G. New signals from the invasive front. Nature 2006; 441(7092):444-50.
2. Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009; 1(6-7):303-14.
3. Wu Y, Zhou BP. Inflammation: a driving force speeds cancer metastasis. Cell Cycle 2009; 8(20):3267-3273.
4. Miettinen PJ, Ebner R, Lopez AR, Derynck R. Tgf-Beta Induced Transdifferentiation of Mammary Epithelial-Cells to Mesenchymal Cells-Involvement of Type-I Receptors. J Cell Biology 1994; 127(6):2021-36.
5. Wu Y, Deng J, Rychahou PG, Qiu SM, Evers BM, Zhou BPH. Stabilization of Snail by NF-kappa B Is Required for Inflammation-Induced Cell Migration and Invasion. Cancer Cell 2009; 15(5):416-28.
6. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investigation 2009; 119(6):1420-8.
7. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell 2009; 139(5):871-90.
8. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Bioch Bioph Sin 2008, 40(7):643-50.
9. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15(6):740-6.
10. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2(6):442-54.
11. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005; 12(6):488-96.
12. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005; 65(14):5991-5; discussion 5995.
13. Li XX, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer I 2008, 100(9):672-9.
14. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133(4):704-15.
15. Moody SE, Perez D, Pan TC, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8(3):197-209.
16. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9(4):265-73.
17. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447(7143):433-40.
18. Wang Y, Fischle W, Cheung W, Jacobs S, Khorasanizadeh S, Allis CD. Beyond the double helix: writing and reading the histone code. Novartis Found Symp 2004; 259:3-17; discussion 17-21, 163-9.
19. Turner BM. Defining an epigenetic code. Nat Cell Biol 2007; 9(1):2-6.
20. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293(5532):1074-80.
21. Campos EI, Reinberg D. Histones: Annotating Chromatin. Ann Rev Genetics 2009; 43:559-99.
22. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genetics 2009; 10(5):295-304.
23. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447(7143):425-32.
24. Gorisch SM, Wachsmuth M, Toth KF, Lichter P, Rippe K. Histone acetylation increases chromatin accessibility. J Cell Sci 2005; 118(24):5825-34.
25. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8(11):829-33.
26. Gelato KA, Fischle W. Role of histone modifications in defining chromatin structure and function. Biological Chem 2008; 389(4):353-63.
27. Marmorstein R, Trievel RC. Histone modifying enzymes: structures, mechanisms, and specificities. Biochim Biophys Acta 2009; 1789(1):58-68.
28. Lennartsson A, Ekwall K. Histone modification patterns and epigenetic codes. Biochim Biophys Acta 2009; 1790(9):863-8.
29. Suganuma T, Workman JL. Signals and combinatorial functions of histone modifications. Annu Rev Biochem 2011; 80:473-99.
30. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011; 21(3):381-95.
31. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10(5):295-304.
32. McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clinical cancer research: an official J Am Assoc Cancer Res 2009; 15(12):3927-37.
33. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324(5929):930-5.
34. Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010; 11(9):607-20.
35. Nabel CS, Kohli RM. Molecular biology. Demystifying DNA demethylation. Science 2011; 333(6047):1229-30.
36. Jin B, Li Y, Robertson KD. DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer 2011; 2(6):607-17.
37. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15(5):490-5.
38. Suganuma T, Workman JL. Crosstalk among Histone Modifications. Cell 2008; 135(4):604-7.
39. Ooi SK, Qiu C, Bernstein E, et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007; 448(7154):714-7.
40. Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H. The role of DNA methylation in setting up chromatin structure during development. Nat Genet 2003; 34(2):187-92.
41. Lande-Diner L, Zhang J, Ben-Porath I, et al. Role of DNA methylation in stable gene repression. The J biological chemistry 2007; 282(16):12194-200.
42. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010, 31(1):27-36.
43. Jones PA. Overview of cancer epigenetics. Semin Hematol 2005; 42(3 Suppl 2):S3-8.
44. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128(4):683-92.
45. Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 2011; 30(9):603-11.
46. Bergamaschi A, Hjortland GO, Triulzi T, et al. Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Mol Oncol 2009; 3(5-6):469-82.
47. Blick T, Widodo E, Hugo H, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 2008; 25(6):629-42.
48. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69(10):4116-24.
49. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008, 68(4):989-97.
50. Storci G, Sansone P, Trere D, et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008, 214(1):25-37.
51. Carver EA, Jiang RL, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cellular Biol 2001; 21(23):8184-8.
52. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3(3):155-66.
53. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132(14):3151-61.
54. Cheng CW, Wu PE, Yu JC, et al. Mechanisms of inactivation of Ecadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001; 20(29):3814-23.
55. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21(20):3241-6.
56. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelialmesenchymal transition. Nat Cell Biol 2004; 6(10):931-40.
57. Nibu Y, Zhang HL, Bajor E, Barolo S, Small S, Levine M. dCtBP mediates transcriptional repression by Knirps, Kruppel and Snail in the Drosophila embryo. Embo J 1998; 17(23):7009-20.
58. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates Ecadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24(1):306-19.
59. Mutskov VJ, Farrell CM, Wade PA, Wolffe AP, Felsenfeld G. The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation. Genes Dev 2002; 16(12):1540-54.
60. Ou JN, Torrisani J, Unterberger A, et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 2007; 73(9):1297-307.
61. Spurling CC, Suhl JA, Boucher N, Nelson CE, Rosenberg DW, Giardina C. The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. Nutr Cancer 2008; 60(5):692-702.
62. Smith KM, Dobosy JR, Reifsnyder JE, et al. H2B-and H3-specific histone deacetylases are required for DNA methylation in Neurospora crassa. Genetics 2010; 186(4):1207-16.
63. Herranz N, Pasini D, Diaz VM, et al. Polycomb complex 2 is required for E-cadherin repression by the snail1 transcription factor. Mol Cellular Biol 2008; 28(15):4772-81.
64. Cao R, Wang LJ, Wang HB, et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 2002; 298(5595):1039-43.
65. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 2007; 128(4):735-45.
66. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 2003; 112(5):599-606.
67. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genomewide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20(9):1123-36.
68. Hou Z, Peng H, Ayyanathan K, et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 2008; 28(10):3198-207.
69. Langer EM, Feng Y, Zhaoyuan H, Rauscher FJ, 3rd, Kroll KL, Longmore GD. Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus. Dev Cell 2008; 14(3):424-36.
70. Poux S, Melfi R, Pirrotta V. Establishment of Polycomb silencing requires a transient interaction between PC and ESC. Genes Dev 2001; 15(19):2509-14.
71. van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 1999; 23(4):474-8.
72. Lin Y, Wu Y, Li J, et al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. The EMBO journal 2010; 29(11):1803-16.
73. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19(6):857-64.
74. Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119(7):941-53.
75. Amente S, Bertoni A, Morano A, Lania L, Avvedimento EV, Majello B. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 2010; 29(25):3691-702.
76. Su ST, Ying HY, Chiu YK, Lin FR, Chen MY, Lin KI. Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol Cell Biol 2009; 29(6):1421-31.
77. Tsai WW, Nguyen TT, Shi Y, Barton MC. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008; 28(17):5139-46.
78. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27(4):562-72.
79. Kahl P, Gullotti L, Heukamp LC, et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006; 66(23):11341-7.
80. Metzger E, Wissmann M, Yin N, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437(7057):436-9.
81. Lim S, Janzer A, Becker A, et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010; 31(3):512-20.
82. Baron R, Binda C, Tortorici M, McCammon JA, Mattevi A. Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST Complex. Structure 2011; 19(2):212-20.
83. Grewal SI, Jia S. Heterochromatin revisited. Nat Rev Genet 2007; 8(1):35-46.
84. Mohn F, Schubeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 2009; 25(3):129-36.
85. Brenner C, Fuks F. A methylation rendezvous: reader meets writers. Dev Cell 2007; 12(6):843-4.
86. Chin HG, Esteve PO, Pradhan M, et al. Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res 2007; 35(21):7313-23.
87. Dong C, Wu Y, Yao J, et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 2012; 122(4):1469-86.
88. Dong KB, Maksakova IA, Mohn F, et al. DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J 2008; 27(20):2691-701.
89. Smallwood A, Esteve PO, Pradhan S, Carey M. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 2007; 21(10):1169-78.
90. Lehnertz B, Ueda Y, Derijck AA, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003; 13(14):1192-200.
91. Peters AH, Kubicek S, Mechtler K, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Molecular Cell 2003; 12(6):1577-89.
92. Rea S, Eisenhaber F, O'Carroll D, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406(6796):593-9.
93. Fritsch L, Robin P, Mathieu JR, et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol cell 2010; 37(1):46-56.
94. Cheng X, Blumenthal RM. Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 2010; 49(14):2999-3008.
95. Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 2011; 25(8):781-8.
96. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP. Stabilization of snail by NF-kappaB is required for inflammationinduced cell migration and invasion. Cancer Cell 2009; 15(5):416-28.
97. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436(7047):123-7.
98. Park SH, Cheung LW, Wong AS, Leung PC. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 2008; 22(9):2085-98.
99. Labelle M, Begum S, Hynes RO. Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell 2011; 20(5):576-90.
100. Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001; 276(27):24661-6.
101. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 2007; 13(16):4769-76.
102. Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK. The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 2005; 50(1):42-6.
103. Merikallio H, Turpeenniemi-Hujanen T, Paakko P, et al. Snail promotes an invasive phenotype in lung carcinoma. Respir Res 2012; 13:104.
104. Smith BN, Odero-Marah VA. The role of Snail in prostate cancer. Cell Adh Migr 2012; 6(5):433-41.
105. Chan DW, Wang Y, Wu M, Wong JM, Qin J, Zhao YM. Unbiased proteomic screen for binding proteins to modified lysines on histone H3. Proteomics 2009; 9(9):2343-54.
106. Gal-Yam EN, Egger G, Iniguez L, et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. P Natl Acad Sci USA 2008; 105(35):12979-84.
107. Lindroth AM, Park YJ, McLean CM, et al. Antagonism between DNA and H3K27 Methylation at the Imprinted Rasgrf1 Locus. Plos Genetics 2008; 4(8).
108. Kondo Y, Shen L, Cheng AS, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40(6):741-50.
109. Issa JP, Kantarjian H. Azacitidine. Nature reviews Drug discovery 2005; Suppl:S6-7.
110. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25(1):84-90.
111. Di Fazio P, Montalbano R, Quint K, et al. The pan-deacetylase inhibitor panobinostat modulates the expression of epithelialmesenchymal transition markers in hepatocellular carcinoma models. Oncology Letters 2013; 5(1):127-34.
112. Ryningen A, Stapnes C, Bruserud O. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. Leukemia Res 2007; 31(9):1303-13.
113. Schulte JH, Lim SY, Schramm A, et al. Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy. Cancer Res 2009; 69(5):2065-71.
114. Huang Y, Greene E, Stewart TM, et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA 2007; 104(19):8023-8.
115. Schenk T, Chen WC, Gollner S, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 2012; 18(4):605-11.
116. Harris WJ, Huang X, Lynch JT, et al. The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells. Cancer Cell 2012; 21(4):473-87.
117. Spannhoff A, Hauser AT, Heinke R, Sippl W, Jung M. The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors. Chemmedchem 2009; 4(10):1568-82.